Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Change in Accured Expenses: 2015-2024

Historic Change in Accured Expenses for Anaptysbio (ANAB) over the last 10 years, with Dec 2024 value amounting to -$33.8 million.

  • Anaptysbio's Change in Accured Expenses fell 651.75% to -$18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$105.0 million, marking a year-over-year decrease of 2327.55%. This contributed to the annual value of -$33.8 million for FY2024, which is 409.35% down from last year.
  • Anaptysbio's Change in Accured Expenses amounted to -$33.8 million in FY2024, which was down 409.35% from $10.9 million recorded in FY2023.
  • In the past 5 years, Anaptysbio's Change in Accured Expenses registered a high of $10.9 million during FY2023, and its lowest value of -$33.8 million during FY2024.
  • In the last 3 years, Anaptysbio's Change in Accured Expenses had a median value of $9.7 million in 2022 and averaged -$4.4 million.
  • Per our database at Business Quant, Anaptysbio's Change in Accured Expenses surged by 304.64% in 2022 and then crashed by 409.35% in 2024.
  • Yearly analysis of 5 years shows Anaptysbio's Change in Accured Expenses stood at -$7.7 million in 2020, then skyrocketed by 38.39% to -$4.7 million in 2021, then soared by 304.64% to $9.7 million in 2022, then rose by 12.76% to $10.9 million in 2023, then crashed by 409.35% to -$33.8 million in 2024.